Senior Research Associate jobs in United States
cer-icon
Apply on Employer Site
company-logo

TreeFrog Therapeutics · 1 month ago

Senior Research Associate

TreeFrog Therapeutics is an innovative biotechnology company focused on developing cell therapies using their C-STEM encapsulation technology. The Senior Research Associate will support internal research activities and collaborations by growing and differentiating iPS cells, while also optimizing methods and analyzing differentiated cell products.

BiopharmaBiotechnologyTherapeutics
badNo H1Bnote

Responsibilities

Culture and differentiation of iPS in multiple 2D and 3D formats
Encapsulation and expansion of iPS cells in TreeFrog’s C-STEM capsule technology
Testing and optimizing differentiation methods within the C-STEM platform
Routine analysis of differentiated cell products including
Flow cytometry
2D cytochemistry
3D immunocytochemistry
Protein analysis (ELISA, western blot, etc.)
RNA analysis (Real Time RT-PCR, RNAseq)
Support method development efforts involving the C-STEM platform
Routine laboratory maintenance
Diligent record keeping and thorough electronic lab notebook practices

Qualification

Stem cell cultureDifferentiation protocol optimizationFlow cytometryTissue culture techniqueRecord keepingTeam collaborationSelf-motivation

Required

B.S. or equivalent in Biology or a related field
Excellent tissue culture technique and ability to maintain large number of cultures at once
Experience in differentiation protocol optimization and development
Flow cytometry sample preparation and data analysis
Self-motivated, independent laboratory scientist
Ability to work in a larger research team and communicate effectively with other team members
Ability to work limited weekend hours

Preferred

Previous stem cell culture and differentiation experience (industry preferred)

Company

TreeFrog Therapeutics

twittertwittertwitter
company-logo
TreeFrog Therapeutics is a stem cell company that will enable millions of patients to access the medical revolution of cell therapies.

Funding

Current Stage
Growth Stage
Total Funding
$121.08M
Key Investors
European Investment BankEIC AcceleratorBpifrance
2025-05-27Debt Financing· $34.2M
2025-02-17Series Unknown
2021-09-13Series B· $75.59M

Leadership Team

leader-logo
Kévin Alessandri
Co-founder, CTO
linkedin
leader-logo
Daniel Castro
Chief Business Officer
linkedin
Company data provided by crunchbase